programmed cell death ligand-1

You have access
Clinicopathological and Molecular Characteristics Promoting PD-L1 Expression in Early-stage Lung Adenocarcinoma and Squamous Cell Carcinoma
ATSUSHI ITO, TOMOHITO TARUKAWA, YUTA SUZUKI, TADASHI SAKAGUCHI, KENTARO ITO, KENTARO FUJIWARA, YOICHI NISHII, OSAMU TAGUCHI, HIROKI YASUI, MOTOSHI TAKAO and OSAMU HATAJI

Anticancer Research November 2023, 43 (11) 5197-5204; DOI: https://doi.org/10.21873/anticanres.16721
You have access
Up-regulation of HDAC6 Results in Poor Prognosis and Chemoresistance in Patients With Advanced Ovarian High-grade Serous Carcinoma
MITSUTAKE YANO, MARIKO MIYAZAWA, NAOKI OGANE, AIKO OGASAWARA, KOSEI HASEGAWA, HISASHI NARAHARA and MASANORI YASUDA

Anticancer Research March 2021, 41 (3) 1647-1654; DOI: https://doi.org/10.21873/anticanres.14927

Main menu